Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

Novo Nordisk’s recent introduction of a direct-to-patient delivery model for its weight-loss drug Wegovy in the United States could potentially delay its availability in India, industry analysts ...

Europe’s largest pharmaceutical firm, Novo Nordisk, has announced that it will offer its most popular weight-loss drug, Wegovy, for less than half of its listed price. This follows a similar ...

Novo Nordisk launched a direct-to-consumer program last week to sell Wegovy at a reduced price for people who are uninsured or insured on commercial plans that don't cover the obesity drug. Through ...

Novo Nordisk has lowered Wegovy's monthly cost by 23%, and Eli Lilly cut prices for Zepbound's starter dose to $349 per month. HealthDay News — The makers of two popular weight-loss drugs — Wegovy and ...

The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another new patent | Complaint similar but separate to previous lawsuit against Mylan and Sun ...

Weight-loss jabs have become so popular that a quick rummage inside any midlife woman's fridge might be enough to reveal an injection pen nestling alongside the sugar-free yoghurts and diet drinks.

March 10 (Reuters) - The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of Novo Nordisk's (NOVOb.CO), opens new tab weight ...